Clinical Trials Browser

Phase 2 × Kidney Neoplasms × lenvatinib × Clear all

NCT06962787 2025-11-17

A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer

Phase 2 Recruiting

Kidney Neoplasms

NCT04393350 2025-02-26

Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms